Radioactive stents are used to treat coronary artery disease. They can be placed in the arteries that supply blood flow to your heart muscle, and they help prevent future blockages from forming by keeping plaque buildup at bay.
Industry Growth Insights published a new data on “Radioactive Stent Market”. The research report is titled “Radioactive Stent Market research by Types (Retrograde Stents, Antegrade Stents, Internal (double-J) Stents), By Applications (Lithotripsy, Ureteroscopy, Ureteroenoscopy, Percutaneous Nephrolithotomy), By Players/Companies C.R. Bard, Cook Medical, Medline Industries, Pnn Medical A/S, Allium Medical Solutions Ltd”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Radioactive Stent Market Research Report
By Type
Retrograde Stents, Antegrade Stents, Internal (double-J) Stents
By Application
Lithotripsy, Ureteroscopy, Ureteroenoscopy, Percutaneous Nephrolithotomy
By Companies
C.R. Bard, Cook Medical, Medline Industries, Pnn Medical A/S, Allium Medical Solutions Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Radioactive Stent Market Report Segments:
The global Radioactive Stent market is segmented on the basis of:
Types
Retrograde Stents, Antegrade Stents, Internal (double-J) Stents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Lithotripsy, Ureteroscopy, Ureteroenoscopy, Percutaneous Nephrolithotomy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- C.R. Bard
- Cook Medical
- Medline Industries
- Pnn Medical A/S
- Allium Medical Solutions Ltd
Highlights of The Radioactive Stent Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Retrograde Stents
- Antegrade Stents
- Internal (double-J) Stents
- By Application:
- Lithotripsy
- Ureteroscopy
- Ureteroenoscopy
- Percutaneous Nephrolithotomy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radioactive Stent Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radioactive stents are medical devices that use radioactive material to help keep a blood vessel open. The radioactive material helps to destroy any abnormal cells or tissue in the area, which can help prevent a reoccurrence of the problem.
Some of the key players operating in the radioactive stent market are C.R. Bard, Cook Medical, Medline Industries, Pnn Medical A/S, Allium Medical Solutions Ltd.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Radioactive Stent Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Radioactive Stent Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Radioactive Stent Market - Supply Chain
4.5. Global Radioactive Stent Market Forecast
4.5.1. Radioactive Stent Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Radioactive Stent Market Size (000 Units) and Y-o-Y Growth
4.5.3. Radioactive Stent Market Absolute $ Opportunity
5. Global Radioactive Stent Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Radioactive Stent Market Size and Volume Forecast by Type
5.3.1. Retrograde Stents
5.3.2. Antegrade Stents
5.3.3. Internal (double-J) Stents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Radioactive Stent Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Radioactive Stent Market Size and Volume Forecast by Application
6.3.1. Lithotripsy
6.3.2. Ureteroscopy
6.3.3. Ureteroenoscopy
6.3.4. Percutaneous Nephrolithotomy
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Radioactive Stent Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Radioactive Stent Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Radioactive Stent Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Radioactive Stent Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Radioactive Stent Demand Share Forecast, 2019-2026
9. North America Radioactive Stent Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Radioactive Stent Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Radioactive Stent Market Size and Volume Forecast by Application
9.4.1. Lithotripsy
9.4.2. Ureteroscopy
9.4.3. Ureteroenoscopy
9.4.4. Percutaneous Nephrolithotomy
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Radioactive Stent Market Size and Volume Forecast by Type
9.7.1. Retrograde Stents
9.7.2. Antegrade Stents
9.7.3. Internal (double-J) Stents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Radioactive Stent Demand Share Forecast, 2019-2026
10. Latin America Radioactive Stent Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Radioactive Stent Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Radioactive Stent Market Size and Volume Forecast by Application
10.4.1. Lithotripsy
10.4.2. Ureteroscopy
10.4.3. Ureteroenoscopy
10.4.4. Percutaneous Nephrolithotomy
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Radioactive Stent Market Size and Volume Forecast by Type
10.7.1. Retrograde Stents
10.7.2. Antegrade Stents
10.7.3. Internal (double-J) Stents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Radioactive Stent Demand Share Forecast, 2019-2026
11. Europe Radioactive Stent Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Radioactive Stent Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Radioactive Stent Market Size and Volume Forecast by Application
11.4.1. Lithotripsy
11.4.2. Ureteroscopy
11.4.3. Ureteroenoscopy
11.4.4. Percutaneous Nephrolithotomy
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Radioactive Stent Market Size and Volume Forecast by Type
11.7.1. Retrograde Stents
11.7.2. Antegrade Stents
11.7.3. Internal (double-J) Stents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Radioactive Stent Demand Share, 2019-2026
12. Asia Pacific Radioactive Stent Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Radioactive Stent Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Radioactive Stent Market Size and Volume Forecast by Application
12.4.1. Lithotripsy
12.4.2. Ureteroscopy
12.4.3. Ureteroenoscopy
12.4.4. Percutaneous Nephrolithotomy
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Radioactive Stent Market Size and Volume Forecast by Type
12.7.1. Retrograde Stents
12.7.2. Antegrade Stents
12.7.3. Internal (double-J) Stents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Radioactive Stent Demand Share, 2019-2026
13. Middle East & Africa Radioactive Stent Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Radioactive Stent Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Radioactive Stent Market Size and Volume Forecast by Application
13.4.1. Lithotripsy
13.4.2. Ureteroscopy
13.4.3. Ureteroenoscopy
13.4.4. Percutaneous Nephrolithotomy
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Radioactive Stent Market Size and Volume Forecast by Type
13.7.1. Retrograde Stents
13.7.2. Antegrade Stents
13.7.3. Internal (double-J) Stents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Radioactive Stent Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Radioactive Stent Market: Market Share Analysis
14.2. Radioactive Stent Distributors and Customers
14.3. Radioactive Stent Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. C.R. Bard
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cook Medical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medline Industries
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Pnn Medical A/S
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Allium Medical Solutions Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
